Details of CPPsite entry with Sequence B-GLRK(NIA)RLRKFRNKIKEK |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | B-GLRK(NIA)RLRKFRNKIKEK |
| CPPsite ID | 2602, 2604, |
| PEPTIDE NAME | CF-sC18(NIA), DOTA-sC18(NIA) |
| CHIRALITY | Modified, Modified |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Synthetic, Synthetic |
| CATEGORY | NA, NA |
| SUB CELLULAR LOCALIZATION | Cytoplasmic Vesicles, NA |
| N-TERMINAL MODIFICATION | Amidation, Amidation |
| C-TERMINAL MODIFICATION | NA, NA |
| CHEMICAL MODIFICATION | B, Beta-Alanine; NIA, 2-(2-nitroimidazol-1-yl)acetic acid, B, Beta-Alanine; NIA, 2-(2-nitroimidazol-1-yl)acetic acid ; N terminal chelator DOTA(1,4,7,10-tetraaza-cyclododecane-1,4,7,10-tetraacetic acid) |
| UPTAKE EFFICIENCY | NA, NA |
| PROPOSED UPTAKE MECHANISM | Endocytic pathway, NA |
| INVITRO/INVIVO | In vitro, In vivo |
| CELL LINE | MCF-7 cells, NA |
| In VIVO MODEL | NA, Wistar rats, four female NMRI (nu/nu) mice |
| CARGO | Fluorophore (Carboxyfluorescein), Radioactive copper |
| PMID | 21956822, 21956822 |
| PATENT | Unknown, Unknown |
| Tertiary Structure (Technique) | Not Predicted), Not Predicted), |